These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 15944202)

  • 1. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system.
    Pickering M; Cumiskey D; O'Connor JJ
    Exp Physiol; 2005 Sep; 90(5):663-70. PubMed ID: 15944202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
    Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
    Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate receptors and excitotoxicity.
    Westbrook GL
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():35-50. PubMed ID: 8380238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility.
    Balosso S; Ravizza T; Pierucci M; Calcagno E; Invernizzi R; Di Giovanni G; Esposito E; Vezzani A
    Neuroscience; 2009 Jun; 161(1):293-300. PubMed ID: 19285115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular neuroplasticity mechanisms mediating pain persistence.
    Salter MW
    J Orofac Pain; 2004; 18(4):318-24. PubMed ID: 15636015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of ethanol on hippocampal long-term potentiation and long-term depression are mediated by different mechanisms.
    Izumi Y; Nagashima K; Murayama K; Zorumski CF
    Neuroscience; 2005; 136(2):509-17. PubMed ID: 16216426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK.
    Liu YL; Zhou LJ; Hu NW; Xu JT; Wu CY; Zhang T; Li YY; Liu XG
    Neuropharmacology; 2007 Mar; 52(3):708-15. PubMed ID: 17084420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glutamate--a transmitter in the tensionfield between toxin and trophine].
    Römer KD; Bleich S; Kornhuber J
    Fortschr Neurol Psychiatr; 2003 Jul; 71 Suppl 1():S3-9. PubMed ID: 12947537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms for memory formation].
    Manabe T
    Brain Nerve; 2008 Jul; 60(7):707-15. PubMed ID: 18646610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation.
    Cumiskey D; Butler MP; Moynagh PN; O'connor JJ
    Brain Res; 2007 Mar; 1136(1):13-9. PubMed ID: 17198691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term potentiation inhibition by low-level N-methyl-D-aspartate receptor activation involves calcineurin, nitric oxide, and p38 mitogen-activated protein kinase.
    Izumi Y; Tokuda K; Zorumski CF
    Hippocampus; 2008; 18(3):258-65. PubMed ID: 18000819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia.
    Garry EM; Delaney A; Blackburn-Munro G; Dickinson T; Moss A; Nakalembe I; Robertson DC; Rosie R; Robberecht P; Mitchell R; Fleetwood-Walker SM
    Mol Cell Neurosci; 2005 Dec; 30(4):523-37. PubMed ID: 16202621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
    Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
    Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glutamate receptors in the central nervous system].
    Ozawa S
    No To Shinkei; 2001 Jul; 53(7):605-15. PubMed ID: 11517484
    [No Abstract]   [Full Text] [Related]  

  • 15. NMDA Receptors in glia.
    Verkhratsky A; Kirchhoff F
    Neuroscientist; 2007 Feb; 13(1):28-37. PubMed ID: 17229973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-inflammatory cytokines and their effects in the dentate gyrus.
    Pickering M; O'Connor JJ
    Prog Brain Res; 2007; 163():339-54. PubMed ID: 17765728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired glutamatergic synaptic transmission in the PKU brain.
    Martynyuk AE; Glushakov AV; Sumners C; Laipis PJ; Dennis DM; Seubert CN
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S34-42. PubMed ID: 16153867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of glutamate transporters in astrocytes].
    Tanaka K
    Brain Nerve; 2007 Jul; 59(7):677-88. PubMed ID: 17663138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate and the glutamate receptor system: a target for drug action.
    Bleich S; Römer K; Wiltfang J; Kornhuber J
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S33-40. PubMed ID: 12973748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules.
    Dityatev A; Bukalo O; Schachner M
    Neuron Glia Biol; 2008 Aug; 4(3):197-209. PubMed ID: 19674506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.